SYNERON MEDICAL LTD - ORD SHS (ELOS)

CUSIP: M87245102

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / ORD SHS
Total 13F shares
26,989,058
Share change
-355,537
Total reported value
$251,947,377
Price per share
$9.33
Number of holders
66
Value change
-$3,532,581
Number of buys
30
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP M87245102?
CUSIP M87245102 identifies ELOS - SYNERON MEDICAL LTD - ORD SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SYNERON MEDICAL LTD - ORD SHS (ELOS) as of Q4 2014

As of 31 Dec 2014, SYNERON MEDICAL LTD - ORD SHS (ELOS) was held by 66 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,989,058 shares. The largest 10 holders included RIMA SENVEST MANAGEMENT, L.L.C., Visium Asset Management, LP, NORTH TIDE CAPITAL, LLC, BAUPOST GROUP LLC/MA, BRANDES INVESTMENT PARTNERS, LP, JPMORGAN CHASE & CO, Broadfin Capital, LLC, DALTON GREINER HARTMAN MAHER & CO, HOURGLASS CAPITAL, LLC, and ROYCE & ASSOCIATES LLC. This page lists 66 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.